Immutep (IMMP) Exchange Rate Effect (2015 - 2026)
Immutep's (IMMP) quarterly Exchange Rate Effect came in at -$1.3 million in Q2 2026, down 162.32% on a YoY basis from $2.0 million in Q2 2025, and down 162.32% quarter-over-quarter from $2.0 million in Q2 2025.
Analysis
Immutep (IMMP) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Immutep (IMMP) has reported Exchange Rate Effect for 9 consecutive years, with -$1.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect fell 162.32% year-over-year to -$1.3 million; the trailing twelve-month figure through Jun 2026 stood at $379612.5 (down 82.23% YoY), and the FY2026 full-year result was -$3.2 million, down 174.42% from the prior year.
- Exchange Rate Effect declined to -$1.3 million in Q2 2026 per IMMP's latest filing, from $2.0 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.0 million in Q2 2025 and bottomed at -$1.3 million in Q2 2026.
- Historically, Exchange Rate Effect has averaged $94903.1 across 4 years, with a median of -$192200.8 in 2023.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect soared 1186.91% in 2025, then slumped 162.32% in 2026.
- Over 4 years, Exchange Rate Effect stood at -$197860.1 in 2023, then increased by 5.72% to -$186541.5 in 2024, then jumped by 1186.91% to $2.0 million in 2025, then plunged by 162.32% to -$1.3 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$1.3 million, $2.0 million, and -$186541.5 for Q2 2026, Q2 2025, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -287,000.00 |
| 10 | Immutep | 52.57 Mn | 52.57 Mn | - | -1.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.26 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Jun 30, 2024 | -186,541.49 |
| Jun 30, 2023 | -197,860.09 |
| Dec 31, 2021 | 492,714.19 |
| Jun 30, 2021 | 904,300.39 |
| Dec 31, 2019 | -843,830.52 |
| Jun 30, 2019 | 1.16 Mn |
| Jun 30, 2017 | 407,726.92 |
| Jun 30, 2016 | -73,303.03 |
| Jun 30, 2015 | 756.00 |